Diverse Roles of Lipids in Neonatal Physiology and Development

Neonatology: Questions and Controversies Series Gastroenterology and Nutrition

Volumn , Issue , 2008, Pages 253-277

  Auestad, Nancy ^a,b  

^a KELLOGG COMPANY   (United States)

^b Department of Human Nutrition ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942579367     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3160-4.10013-6     Document Type: Chapter

References (159)

1. Jensen RG Lipids in human milk. Lipids 1999, 34:1243.
2. Koo WW, Hockman EM, Dow M Palm olein in the fat blend of infant formulas: effect on the intestinal absorption of calcium and fat, and bone mineralization. J Am Coll Nutr 2006, 25:117.
3. Hamosh M, Mehta NR, Fink CS, et al. Fat absorption in premature infants: medium-chain triglycerides and long-chain triglycerides are absorbed from formula at similar rates. J Pediatr Gastroenterol Nutr 1991, 13:143.
4. Diaz M, Leal C, Ramon Y, Cajal J, et al. Cord blood lipoprotein-cholesterol: relationship birth weight and gestational age of newborns. Metabolism 1989, 38:435.
5. Kalra A, Kalra K, Agarwal MC, et al. Serum lipid profile in term and preterm infants in early neonatal period. Indian Pediatr 1988, 25:977.
6. Mortaz M, Fewtrell MS, Cole TJ, et al. Cholesterol metabolism in 8 to 12-year-old children born preterm or at term. Acta Paediatr 2003, 92:525.
7. Pardo IM, Geloneze B, Tambascia MA, et al. Atherogenic lipid profile of Brazilian near-term newborns. Braz J Med Biol Res 2005, 38:755.
8. Singhal A, Cole TJ, Fewtrell M, et al. Breastmilk feeding and lipoprotein profile in adolescents born preterm: follow-up of a prospective randomised study. Lancet 2004, 363:1571.
9. Clarke SD The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr Opin Lipidol 2004, 15:13.
10. Innis SM Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 2003, 143:S1.
11. Connor WE, Neuringer M The effects of n-3 fatty acid deficiency and repletion upon the fatty acid composition and function of the brain and retina. Prog Clin Biol Res 1988, 282:275.
12. Jeffrey BG, Mitchell DC, Gibson RA, et al. n-3 fatty acid deficiency alters recovery of the rod photoresponse in rhesus monkeys. Invest Ophthalmol Vis Sci 2002, 43:2806.
13. Lim SY, Hoshiba J, Salem N An extraordinary degree of structural specificity is required in neural phospholipids for optimal brain function: n-6 docosapentaenoic acid substitution for docosahexaenoic acid leads to a loss in spatial task performance. J Neurochem 2005, 95:848.
14. Uauy R, Mena P, Rojas C Essential fatty acids in early life: structural and functional role. Proc Nutr Soc 2000, 59:3.
15. Ma DW, Seo J, Switzer KC, et al. n-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J Nutr Biochem 2004, 15:700.
16. Martinez M Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992, 120:S129.
17. Clandinin MT, Chappell JE, Heim T, et al. Fatty acid utilization in perinatal de novo synthesis of tissues. Early Hum Dev 1981, 5:355.
18. Berghaus TM, Demmelmair H, Koletzko B Fatty acid composition of lipid classes in maternal and cord plasma at birth. Eur J Pediatr 1998, 157:763.
19. Clandinin MT, Wong K, Hacker RR Synthesis of chain elongation-desaturation products of linoleic acid by liver and brain microsomes during development of the pig. Biochem J 1985, 226:305.
20. Dutta-Roy AK Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta. Am J Clin Nutr 2000, 71:315S.
21. Su HM, Huang MC, Saad NM, et al. Fetal baboons convert 18:3 n-3 to 22:6 n-3 in vivo. A stable isotope tracer study. J Lipid Res 2001, 42:581.
22. Haggarty P Effect of placental function on fatty acid requirements during pregnancy. Eur J Clin Nutr 2004, 58:1559.
23. Fuchs R, Ellinger I Endocytic and transcytotic processes in villous syncytiotrophoblast: role in nutrient transport to the human fetus. Traffic 2004, 5:725.
24. Dutta-Roy AK Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding/transport proteins. Cell Mol Life Sci 2000, 57:1360.
25. Knipp GT, Audus KL, Soares MJ Nutrient transport across the placenta. Adv Drug Deliv Rev 1999, 38:41.
26. Campbell FM, Taffesse S, Gordon MJ, et al. Plasma membrane fatty-acid-binding protein in human placenta: identification and characterization. Biochem Biophys Res Commun 1995, 209:1011.
27. Larque E, Demmelmair H, Berger B, et al. In vivo investigation of the placental transfer of (13)C-labeled fatty acids in humans. J Lipid Res 2003, 44:49.
28. Campbell FM, Gordon MJ, Dutta-Roy AK Preferential uptake of long chain polyunsaturated fatty acids by isolated human placental membranes. Mol Cell Biochem 1996, 155:77.
29. Elias SL, Innis SM Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am J Clin Nutr 2001, 73:807.
30. Haggarty P, Ashton J, Joynson M, et al. Effect of maternal polyunsaturated fatty acid concentration on transport by the human placenta. Biol Neonate 1999, 75:350.
31. Kuhn DC, Crawford M Placental essential fatty acid transport and prostaglandin synthesis. Prog Lipid Res 1986, 25:345.
32. Innis SM Essential fatty acids in growth and development. Prog Lipid Res 1991, 30:39.
33. Innis SM Essential fatty acid transfer and fetal development. Placenta 2005, 26 Suppl A:S70.
34. Haggarty P Placental regulation of fatty acid delivery and its effect on fetal growth-a review. Placenta 2002, 23(Suppl A):S28.
35. Kuhn DC, Crawford MA, Stuart MJ, et al. Alterations in transfer and lipid distribution of arachidonic acid in placentas of diabetic pregnancies. Diabetes 1990, 39:914.
36. Wijendran V, Bendel RB, Couch SC, et al. Maternal plasma phospholipid polyunsaturated fatty acids in pregnancy with and without gestational diabetes mellitus: relations with maternal factors. Am J Clin Nutr 1999, 70:53.
37. Wijendran V, Bendel RB, Couch SC, et al. Fetal erythrocyte phospholipid polyunsaturated fatty acids are altered in pregnancy complicated with gestational diabetes mellitus. Lipids 2000, 35:927.
38. Lepercq J, Challier JC, Guerre-Millo M, et al. Prenatal leptin production: evidence that fetal adipose tissue produces leptin. J Clin Endocrinol Metab 2001, 86:2409.
39. Hoggard N, Crabtree J, Allstaff S, et al. Leptin secretion to both the maternal and fetal circulation in the ex vivo perfused human term placenta. Placenta 2001, 22:347.
40. Hoggard N, Haggarty P, Thomas L, et al. Leptin expression in placental and fetal tissues: does leptin have a functional role?. Biochem Soc Trans 2001, 29:57.
41. Yildiz L, Avci B, Ingec M Umbilical cord and maternal blood leptin concentrations in intrauterine growth retardation. Clin Chem Lab Med 2002, 40:1114.
42. Bernstein IM, Goran MI, Amini SB, et al. Differential growth of fetal tissues during the second half of pregnancy. Am J Obstet Gynecol 1997, 176:28.
43. Parretti E, Carignani L, Cioni R, et al. Sonographic evaluation of fetal growth and body composition in women with different degrees of normal glucose metabolism. Diabetes Care 2003, 26:2741.
44. Larciprete G, Valensise H, Vasapollo B, et al. Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies. Ultrasound Obstet Gynecol 2003, 22:591.
45. Min Y, Lowy C, Ghebremeskel K, et al. Unfavorable effect of type 1 and type 2 diabetes on maternal and fetal essential fatty acid status: a potential marker of fetal insulin resistance. Am J Clin Nutr 2005, 82:1162.
46. Ghebremeskel K, Thomas B, Lowy C, et al. Type 1 diabetes compromises plasma arachidonic and docosahexaenoic acids in newborn babies. Lipids 2004, 39:335.
47. Plagemann A Perinatal programming and functional teratogenesis: impact on body weight regulation and obesity. Physiol Behav 2005, 86:661.
48. Garg M, Thamotharan M, Rogers L, et al. Glucose metabolic adaptations in the intrauterine growth-restricted adult female rat offspring. Am J Physiol Endocrinol Metab 2006, 290:E1218.
49. Groh-Wargo S Recommended enteral nutrient intakes. Nutritional care for high-risk neonates 2000, 231. Bonus Books, Los Angeles. 3rd. S. Groh-Wargo, M. Thompson, J. Cox (Eds.).
50. Symonds ME, Mostyn A, Pearce S, et al. Endocrine and nutritional regulation of fetal adipose tissue development. J Endocrinol 2003, 179:293.
51. Dobbing J, Sands J Quantitative growth and development of human brain. Arch Dis Child 1973, 48:757.
52. Dobbing J, Sands J Comparative aspects of the brain growth spurt. Early Hum Dev 1979, 3:79.
53. Georgieff MK, Innis SM Controversial nutrients that potentially affect preterm neurodevelopment: essential fatty acids and iron. Pediatr Res 2005, 57:99R.
54. Clandinin MT, Chappell JE, Leong S, et al. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 1980, 4:121.
55. Al MD, van Houwelingen AC, Hornstra G Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. Am J Clin Nutr 2000, 71:285S.
56. Colombo J, Kannass KN, Shaddy DJ, et al. Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev 2004, 75:1254.
57. Smuts CM, Huang M, Mundy D, et al. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 2003, 101:469.
58. Malcolm CA, McCulloch DL, Montgomery C, et al. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child Fetal Neonatal Ed 2003, 88:F383.
59. Montgomery C, Speake BK, Cameron A, et al. Maternal docosahexaenoic acid supplementation and fetal accretion. Br J Nutr 2003, 90:135.
60. Sanjurjo P, Ruiz-Sanz JI, Jimeno P, et al. Supplementation with docosahexaenoic acid in the last trimester of pregnancy: maternal-fetal biochemical findings. J Perinat Med 2004, 32:132.
61. Helland IB, Smith L, Saarem K, et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003, 111:e39.
62. Helland IB, Saugstad OD, Smith L, et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 2001, 108:E82.
63. Lauritzen L, Jorgensen MH, Mikkelsen TB, et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n-3 fatty acid content of infant erythrocytes. Lipids 2004, 39:195.
64. Jensen CL, Voigt RG, Prager TC, et al. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am J Clin Nutr 2005, 82:125.
65. Boris J, Jensen B, Salvig JD, et al. A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n-3 fatty acid content in human breast milk. Lipids 2004, 39:1191.
66. Makrides M, Neumann MA, Gibson RA Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr 1996, 50:352.
67. Gibson RA, Neumann MA, Makrides M Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur J Clin Nutr 1997, 51:578.
68. Al MD, van Houwelingen AC, Hornstra G Relation between birth order and the maternal and neonatal docosahexaenoic acid status. Eur J Clin Nutr 1997, 51:548.
69. Meyer BJ, Mann NJ, Lewis JL, et al. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003, 38:391.
70. Astorg P, Arnault N, Czernichow S, et al. Dietary intakes and food sources of n-6 and n-3 PUFA in French adult men and women. Lipids 2004, 39:527.
71. Kuriki K, Nagaya T, Tokudome Y, et al. Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study. J Nutr 2003, 133:3643.
72. Yamada T, Strong JP, Ishii T, et al. Atherosclerosis and omega-3 fatty acids in the populations of a fishing village and a farming village in Japan. Atherosclerosis 2000, 153:469.
73. Groh-Wargo S Recommended enteral nutrient intakes. Nutritional care for high-risk neonates 2000, 231. Bonus Books, Los Angeles. 3rd. S. Groh-Wargo, M. Thompson, J. Cox (Eds.).
74. Roy CC, Ste-Marie M, Chartrand L, et al. Correction of the malabsorption of the preterm infant with a medium-chain triglyceride formula. J Pediatr 1975, 86:446.
75. Hamosh M Bile-salt-stimulated lipase of human milk and fat digestion in the preterm infant. J Pediatr Gastroenterol Nutr 2 Suppl 1983, 1:S248.
76. Liao TH, Hamosh P, Hamosh M Fat digestion by lingual lipase: mechanism of lipolysis in the stomach and upper small intestine. Pediatr Res 1984, 18:402.
77. Hamosh M Digestion in the newborn. Clin Perinatol 1996, 23:191.
78. Rings EH, Minich DM, Vonk RJ, et al. Functional development of fat absorption in term and preterm neonates strongly correlates with ability to absorb long-chain fatty acids from intestinal lumen. Pediatr Res 2002, 51:57.
79. Kovacs A, Funke S, Marosvolgyi T, et al. Fatty acids in early human milk after preterm and full-term delivery. J Pediatr Gastroenterol Nutr 2005, 41:454.
80. Genzel-Boroviczeny O, Wahle J, Koletzko B Fatty acid composition of human milk during the 1st month after term and preterm delivery. Eur J Pediatr 1997, 156:142.
81. Bitman J, Wood DL, Mehta NR, et al. Comparison of the cholesteryl ester composition of human milk from preterm and term mothers. J Pediatr Gastroenterol Nutr 1986, 5:780.
82. Bitman J, Wood DL, Mehta NR, et al. Comparison of the phospholipid composition of breast milk from mothers of term and preterm infants during lactation. Am J Clin Nutr 1984, 40:1103.
83. Bitman J, Wood L, Hamosh M, et al. Comparison of the lipid composition of breast milk from mothers of term and preterm infants. Am J Clin Nutr 1983, 38:300.
84. Al-Tamer YY, Mahmood AA Fatty-acid composition of the colostrum and serum of fullterm and preterm delivering Iraqi mothers. Eur J Clin Nutr 2004, 58:1119.
85. Davis A, Baker S The use of modular nutrients in pediatrics. J Parenter Enteral Nutr 1996, 20:228.
86. Romera G, Figueras J, Rodriguez-Miguelez JM, et al. Energy intake, metabolic balance and growth in preterm infants fed formulas with different nonprotein energy supplements. J Pediatr Gastroenterol Nutr 2004, 38:407.
87. Rey J, Schmitz J, Amedee-Manesme O Fat absorption in low birthweight infants. Acta Paediatr Scand Suppl 1982, 296:81.
88. Hamosh M, Bitman J, Liao TH, et al. Gastric lipolysis and fat absorption in preterm infants: effect of medium-chain triglyceride or long-chain triglyceride-containing formulas. Pediatrics 1989, 83:86.
89. Sulkers EJ, von Goudoever JB, Leunisse C, et al. Comparison of two preterm formulas with or without addition of medium-chain triglycerides (MCTs). I. Effects on nitrogen and fat balance and body composition changes. J Pediatr Gastroenterol Nutr 1992, 15:34.
90. Sulkers EJ, Lafeber HN, Degenhart HJ, et al. Comparison of two preterm formulas with or without addition of medium-chain triglycerides (MCTs). II. Effects on mineral balance. J Pediatr Gastroenterol Nutr 1992, 15:42.
91. Sulkers EJ, Lafeber HN, Sauer PJ Quantitation of oxidation of medium-chain triglycerides in preterm infants. Pediatr Res 1989, 26:294.
92. Sulkers EJ, Lafeber HN, van Goudoever JB, et al. Decreased glucose oxidation in preterm infants fed a formula containing medium-chain triglycerides. Pediatr Res 1993, 33:101.
93. Carnielli VP, Rossi K, Badon T, et al. Medium-chain triacylglycerols in formulas for preterm infants: effect on plasma lipids, circulating concentrations of medium-chain fatty acids, and essential fatty acids. Am J Clin Nutr 1996, 64:152.
94. Rodriguez A, Raederstorff D, Sarda P, et al. Preterm infant formula supplementation with alpha linolenic acid and docosahexaenoic acid. Eur J Clin Nutr 2003, 57:727.
95. Telliez F, Bach V, Leke A, et al. Feeding behavior in neonates whose diet contained medium-chain triacylglycerols: short-term effects on thermoregulation and sleep. Am J Clin Nutr 2002, 76:1091.
96. Baumgart S, Pereira GR, Bennett MJ Excretion of dicarboxylic acids in preterm infants fed medium- or long-chain triglycerides. J Pediatr 1994, 125:509.
97. Henderson MJ, Dear PR Dicarboxylic aciduria and medium chain triglyceride supplemented milk. Arch Dis Child 1986, 61:610.
98. Whyte RK, Whelan D, Hill R, et al. Excretion of dicarboxylic and omega-1 hydroxy fatty acids by low birth weight infants fed with medium-chain triglycerides. Pediatr Res 1986, 20:122.
99. Wu PY, Edmond J, Auestad N, et al. Medium-chain triglycerides in infant formulas and their relation to plasma ketone body concentrations. Pediatr Res 1986, 20:338.
100. Wu PY, Edmond J, Morrow JW, et al. Gastrointestinal tolerance, fat absorption, plasma ketone and urinary dicarboxylic acid levels in low-birth-weight infants fed different amounts of medium-chain triglycerides in formula. J Pediatr Gastroenterol Nutr 1993, 17:145.
101. Klenoff-Brumberg HL, Genen LH. High versus low medium chain triglyceride content of formula for promoting short term growth of preterm infants. Cochrane Database Syst Rev 2003; CD002777.
102. Klein CJ Nutrient requirements for preterm infant formulas. J Nutr 2002, 132:1395S.
103. Carlson SE Arachidonic acid status of human infants: influence of gestational age at birth and diets with very long chain n-3 and n-6 fatty acids. J Nutr 1996, 126:1092S.
104. Carlson SE, Werkman SH, Tolley EA Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am J Clin Nutr 1996, 63:687.
105. Carlson SE, Cooke RJ, Werkman SH, et al. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 1992, 27:901.
106. Carlson SE, Werkman SH, Peeples JM, et al. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA 1993, 90:1073.
107. Ryan AS, Montalto MB, Groh-Wargo S, et al. Effect of DHA-containing formula on growth of preterm infants to 59 weeks postmenstrual age. Am J Human Biol 1999, 11:457.
108. Vanderhoof J, Gross S, Hegyi T A multicenter long-term safety and efficacy trial of preterm formula supplemented with long-chain polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr 2000, 31:121.
109. Innis SM, Adamkin DH, Hall RT, et al. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. J Pediatr 2002, 140:547.
110. Clandinin MT, Van Aerde JE, Merkel KL, et al. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr 2005, 146:461.
111. O'Connor DL, Hall R, Adamkin D, et al. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 2001, 108:359.
112. Groh-Wargo S, Jacobs J, Auestad N, et al. Body composition in preterm infants who are fed long-chain polyunsaturated fatty acids: a prospective, randomized, controlled trial. Pediatr Res 2005, 57:712.
113. Farquharson J, Cockburn F, Patrick WA, et al. Effect of diet on infant subcutaneous tissue triglyceride fatty acids. Arch Dis Child 1993, 69:589.
114. Fleith M, Clandinin MT Dietary PUFA for preterm and term infants: review of clinical studies. Crit Rev Food Sci Nutr 2005, 45:205.
115. Alessandri JM, Guesnet P, Vancassel S, et al. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev 2004, 44:509.
116. Heird WC Biochemical homeostasis and body growth are reliable end points in clinical nutrition trials. Proc Nutr Soc 2005, 64:297.
117. Heird WC, Lapillonne A The role of essential fatty acids in development. Annu Rev Nutr 2005, 25:549.
118. Innis SM Polyunsaturated fatty acids in human milk: an essential role in infant development. Adv Exp Med Biol 2004, 554:27.
119. Makrides M, Gibson RA, Udell T, et al. Supplementation of infant formula with long-chain polyunsaturated fatty acids does not influence the growth of term infants. Am J Clin Nutr 2005, 81:1094.
120. McCann JC, Ames BN Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 2005, 82:281.
121. SanGiovanni JP, Chew EY The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 2005, 24:87.
122. Simmer K, Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2004;CD000375.
123. Smithers LG, McPhee AJ, Gibson RA, et al. Visual development of preterm infants fed high dose docosahexaenoic acid. Asia Pac J Clin Nutr 2004, 13:S50.
124. Carlson SE, Werkman SH, Peeples JM, et al. Long-chain fatty acids and early visual and cognitive development of preterm infants. Eur J Clin Nutr 1994, 48 Suppl 2:S27.
125. Carlson SE, Werkman SH, Rhodes PG, et al. Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation. Am J Clin Nutr 1993, 58:35.
126. O'Connor AR, Stephenson TJ, Johnson A, et al. Visual function in low birthweight children. Br J Ophthalmol 2004, 88:1149.
127. O'Connor DL, Jacobs J, Hall R, et al. Growth and development of premature infants fed predominantly human milk, predominantly premature infant formula, or a combination of human milk and premature formula. J Pediatr Gastroenterol Nutr 2003, 37:437.
128. Calder PC, Grimble RF Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr 2002, 56 Suppl 3:S14.
129. Harbige LS Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 2003, 38:323.
130. Field CJ, Clandinin MT, Van Aerde JE Polyunsaturated fatty acids and T-cell function: implications for the neonate. Lipids 2001, 36:1025.
131. Jenski LJ, Bowker GM, Johnson MA, et al. Docosahexaenoic acid-induced alteration of Thy-1 and CD8 expression on murine splenocytes. Biochim Biophys Acta 1995, 1236:39.
132. Field CJ, Thomson CA, Van Aerde JE, et al. Lower proportion of CD45R0 + cells and deficient interleukin-10 production by formula-fed infants, compared with human-fed, is corrected with supplementation of long-chain polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr 2000, 31:291.
133. Cerbulo-Vazquez A, Valdes-Ramos R, Santos-Argumedo L Activated umbilical cord blood cells from pre-term and term neonates express CD69 and synthesize IL-2 but are unable to produce IFN-gamma. Arch Med Res 2003, 34:100.
134. Gasparoni A, Ciardelli L, Avanzini A, et al. Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol Neonate 2003, 84:297.
135. Juretic E, Juretic A, Uzarevic B, et al. Alterations in lymphocyte phenotype of infected preterm newborns. Biol Neonate 2001, 80:223.
136. Juretic E, Uzarevic B, Petrovecki M, et al. Two-color flow cytometric analysis of preterm and term newborn lymphocytes. Immunobiology 2000, 202:421.
137. Herz U, Petschow B Perinatal events affecting the onset of allergic diseases. Curr Drug Targets Inflamm Allergy 2005, 4:523.
138. Satwani P, Morris E, van de Ven C, et al. Dysregulation of expression of immunoregulatory and cytokine genes and its association with the immaturity in neonatal phagocytic and cellular immunity. Biol Neonate 2005, 88:214.
139. Thornton CA, Upham JW, Wikstrom ME, et al. Functional maturation of CD4 + CD25 + CTLA4 + CD45RA + T regulatory cells in human neonatal T cell responses to environmental antigens/allergens. J Immunol 2004, 173:3084.
140. Holt PG Programming for responsiveness to environmental antigens that trigger allergic respiratory disease in adulthood is initiated during the perinatal period. Environ Health Perspect 1998, 106(Suppl 3):795.
141. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998, 160:4730.
142. Steffensen FH, Sorensen HT, Gillman MW, et al. Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology 2000, 11:185.
143. Prescott SL, Calder PC n-3 polyunsaturated fatty acids and allergic disease. Curr Opin Clin Nutr Metab Care 2004, 7:123.
144. Nafstad P, Nystad W, Magnus P, et al. Asthma and allergic rhinitis at 4 years of age in relation to fish consumption in infancy. J Asthma 2003, 40:343.
145. Dunstan JA, Mori TA, Barden A, et al. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J Allergy Clin Immunol 2003, 112:1178.
146. Mihrshahi S, Peat JK, Marks GB, et al. Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the Childhood Asthma Prevention Study (CAPS). J Allergy Clin Immunol 2003, 111:162.
147. Mihrshahi S, Peat JK, Webb K, et al. Effect of omega-3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age. Pediatr Allergy Immunol 2004, 15:517.
148. Mihrshahi S, Vukasin N, Forbes S, et al. Are you busy for the next 5 years? Recruitment in the Childhood Asthma Prevention Study (CAPS). Respirology 2002, 7:147.
149. Peat JK, Mihrshahi S, Kemp AS, et al. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. J Allergy Clin Immunol 2004, 114:807.
150. Kidd P Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003, 8:223.
151. Klein TW, Newton C, Larsen K, et al. The cannabinoid system and immune modulation. J Leukoc Biol 2003, 74:486.
152. Jump DB, Clarke SD Regulation of gene expression by dietary fat. Annu Rev Nutr 1999, 19:63.
153. Fan YY, McMurray DN, Ly LH, et al. Dietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts. J Nutr 2003, 133:1913.
154. De Caterina R, Massaro M Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J Membr Biol 2005, 206:103.
155. Eschen O, Christensen JH, De Caterina R, et al. Soluble adhesion molecules in healthy subjects: a dose-response study using n-3 fatty acids. Nutr Metab Cardiovasc Dis 2004, 14:180.
156. Wessel J Feeding methodologies. Nutritional care for high-risk neonates 2000, 321. Bonus Books, Los Angeles. 3rd. S. Groh-Wargo, M. Thompson, J. Cox (Eds.).
157. Connor WE, Lowensohn R, Hatcher L Increased docosahexaenoic acid levels in human newborn infants by administration of sardines and fish oil during pregnancy. Lipids 1996, 31(Suppl):S183.
158. Malcolm CA, Hamilton R, McCulloch DL, et al. Scotopic electroretinogram in term infants born of mothers supplemented with docosahexaenoic acid during pregnancy. Invest Ophthalmol Vis Sci 2003, 44:3685.
159. Helland IB, Saarem K, Saugstad OD, et al. Fatty acid composition in maternal milk and plasma during supplementation with cod liver oil. Eur J Clin Nutr 1998, 52:839.